weSRCH App on Apple
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News


    Total record(s) 1726 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
     

    The Latest Buzz in Biotech - Motley Fool

      We have two stocks that are reminding us as investors that we need to diversify, especially when we're talking about biotech. One of the stocks we're talking about here is Amicus. Amicus is a rare-disease drug developer that already has one drug that' Save |  Share  Email 6th Dec 2016 
     

    Hot Stock for Investors: Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) - FactsReporter

      Frisco Fastball Bellicum Pharmaceuticals, Inc. on 11/07/2016 reported its EPS as $-0.66 with the analysts projecting the EPS of the stock as $-0.63. The company beat the analyst EPS Estimate with the difference of $-0. Save |  Share  Email 6th Dec 2016 
     

    Are China Biologic Products, Inc. (NASDAQ:CBPO) Shares Headed Higher? - AR News

      China Biologic Products, Inc. (NASDAQ:CBPO) shares traded +0.56% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $148.43 within the next 52-weeks. Since analy Save |  Share  Email 6th Dec 2016 
     

    IUDS, implants may be best birth control for women with diabetes - Reuters

      (Reuters Health) - The two most effective hormonal birth control methods for women in general are also excellent options for women with diabetes, according to a new study. Intrauterine devices (IUDs) and contraceptive implants t Save |  Share  Email 6th Dec 2016 
     

    Hispanic adults with diabetes could benefit from peer support interventions - EurekAlert (press release)

      EurekAlert (press release) 6, 2016) -- Diabetes is a global health problem that disproportionally affects individuals of ethnic and racial minorities. Minorities are more likely to experience complic Save |  Share  Email 6th Dec 2016 
     

    Biotech Investment Bank Research Reports To Beg, Borrow And Steal - Forbes

      Forbes A few weeks ago I wrote about resources aimed at independent biotech investors who may not have access to the institutional research reports that we as fund managers take for granted. A logical follow-up questio Save |  Share  Email 6th Dec 2016 
     

    Sanofi, JHL Biotech strike Rituxan biosimilar pact worth up to $236M - FiercePharma

      FiercePharma Sanofi is jumping into the China biosimilars fray in a deal with Taiwan's JHL Biotech. Focused first on JHL's Rituxan biosim, the partnership could be worth up to $236 million in upfront and mileston Save |  Share  Email 6th Dec 2016 
     

    Scientists find mechanism behind side effects in vision-loss treatment - Science Daily

      VEGF inhibitors are also used as anti-cancer drugs, and a known side effect of this is kidney problems that can range from raised blood pressure and development of protein in the urine to severe damage to Save |  Share  Email 6th Dec 2016 
     

    Regenerative Medicine Market to Reach $101.3 billion with 26.0% CAGR Forecast to 2022 - U.S. Politics Today

      According to Stratistics MRC, the Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022 Save |  Share  Email 6th Dec 2016 
     

    Stock's Stunning Activities: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - FactsReporter

      The Cerbat Gem Alnylam Pharmaceuticals, Inc. on 11/02/2016 reported its EPS as $-1.21 with the analysts projecting the EPS of the stock as $-1.14. The company beat the analyst EPS Estimate with the difference of Save |  Share  Email 6th Dec 2016 
     

    Here Are the States with the Lowest & Highest Diabetes Rates - Yahoo News

      Yahoo News Diabetes is on the rise in the United States, and a new poll looks at where the disease is most and least common. In the poll, from Gallup-Healthways, researchers surveyed a nationally representative sample of more Save |  Share  Email 6th Dec 2016 
     

    Merck launches HME excipient with high API loading capacity - In-PharmaTechnologist.com

      Merck has launched a polyvinyl alcohol-based excipient developed for use in drugs produced via hot melt extrusion (HME). The excipient - Parteck MXP - is stable at temperatures of up to 200 degrees Celsius and can a Save |  Share  Email 6th Dec 2016 
     

    Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in ... - Motley Fool

      Motley Fool An influx of capital should help the small biopharma launch its recently approved gastrointestinal drug.Hot Biotech Stocks To Watch Right Now: Progenics Pharmaceuticals ...The Independent Republicall 7 ne Save |  Share  Email 6th Dec 2016 
     

    Hip hop icon wants you to know your diabetes risk factors - fox5sandiego.com

      fox5sandiego.com Rev Run and Simmons are more susceptible to the disease because they are both African Americans over the age of 45 with a family history of type 2 diabetes. Now, they are urging people to visit the AskScreenKno Save |  Share  Email 6th Dec 2016 
     

    Takeda overturns negative EU CHMP opinion in 'face-to-face' appeal - In-PharmaTechnologist.com

      Takeda was awarded conditional EU marketing authorisation of the small molecule drug Ninlaro, overturning the EMA's negative opinion on its efficacy against Multiple Myeloma (MM). Taked Save |  Share  Email 6th Dec 2016 
     

    New East Side Buildings Signs of City's Burgeoning Biotech Industry - NY1

      NY1 New buildings on the East Side of Manhattan are signs of life of the city's foray into a new economy, its burgeoning biotech industry. NY1's Erin Billups filed the following report. New York is known for many thing Save |  Share  Email 6th Dec 2016 
     

    Growing body of research links opioid addiction to genetic factors - Genetic Literacy Project

      Genetic Literacy Project Within the fields of neuropsychiatry and pharmacogenetics, in particular, genetics has emerged as the key to evaluating medications that influence the areas of the brain where we feel t Save |  Share  Email 6th Dec 2016 
     

    AstraZeneca sets out on a $1bn 'Bicycle' path - In-PharmaTechnologist.com

      AstraZeneca has partnered with Bicycle Therapeutics in a potential $1bn deal to develop a new class of small molecules which have antibody-like properties. The Anglo-Swedish pharma giant AstraZeneca will expand its drug d Save |  Share  Email 6th Dec 2016 
     

    BRIEF-Ariad Pharmaceuticals announces results of clinical and translationa... - Reuters

      NEW YORK, Dec 6 (IFR) - Investors have placed US$19bn of orders for a new US dollar bond from Petroleos Mexicanos (Pemex), one of the bankers managing the deal told IFR. BRIEF-Elbit Imaging announces update regardin Save |  Share  Email 6th Dec 2016 
     

    Brokers Offer Predictions for Ra Pharmaceuticals Inc's FY2016 Earnings (RARX) - The Cerbat Gem

      The Cerbat Gem Ra Pharmaceuticals logo Ra Pharmaceuticals Inc (NASDAQ:RARX) - Research analysts at SunTrust Banks dropped their FY2016 earnings per share estimates for shares of Ra Pharmaceuticals in a res Save |  Share  Email 6th Dec 2016 
     
    Total record(s) 1726 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    Save the date: 2016 World Stem Cell Summit & RegMed Capital Conference, Dec. 6-9 Palm Beach County Convention Center, West Palm Beach, Florida.